These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28338236

  • 21. Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
    Li D, Liu SH, Liu QY, Zou QQ, Lv L, Liu GL, Wu Y.
    Cancer Biother Radiopharm; 2021 Aug; 36(6):511-520. PubMed ID: 32589477
    [Abstract] [Full Text] [Related]

  • 22. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes.
    Yan S, Wang T, Huang S, Di Y, Huang Y, Liu X, Luo Z, Han W, An B.
    Acta Diabetol; 2016 Oct; 53(5):693-702. PubMed ID: 27039347
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
    Chen S, Gao C, Yu T, Qu Y, Xiao GG, Huang Z.
    Front Oncol; 2021 Oct; 11():641289. PubMed ID: 34094925
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L, Wu Y, Feng M, Xue X, Fan Y.
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [Abstract] [Full Text] [Related]

  • 29. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y, Yan K, Lin J, Wang J, Zheng Z, Li X, Hua Z, Bu Y, Shi J, Sun S, Li X, Liu Y, Bi J.
    Aging (Albany NY); 2020 Nov 05; 12(21):21854-21873. PubMed ID: 33154194
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S, Gu Y, Huang Y, Wong TC, Ding H, Liu T, Zhang Y, Zhang X.
    Biochem Genet; 2017 Jun 05; 55(3):253-267. PubMed ID: 28315020
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z, Lu C, Lu B, Gao H, Liang R, Xiang W.
    BMC Genomics; 2023 Mar 29; 24(1):162. PubMed ID: 36991314
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.